Semprae Laboratories, Inc.

Quaker BioVentures: Company Profile

Established in 2003, Quaker BioVentures is a venture capital firm specializing in life science companies within the Mid-Atlantic region. The firm leads investments across the industry, spanning biopharmaceuticals, specialty pharmaceuticals, medical devices, human diagnostics and healthcare services.

Quaker BioVentures currently manages over $700 million in committed capital. Its investment team possesses extensive experience in venture capital, operational management and finance, as well as background in all sectors of the life science industry. Its portfolio includes businesses at all stages of development, from startups to publicly-held companies.

For more information about Quaker BioVentures' extensive investment portfolio, visit www.quakerbio.com.

Semprae Board of Directors

ADELE C. OLIVA

Adele Oliva joined Quaker BioVentures as a Partner in June 2007.   Ms. Oliva spent the previous decade at Apax Partners where she was a partner and Co-Head of US Healthcare.  Prior to joining Apax, Ms. Oliva held positions in marketing and business development with Baxter Healthcare's Cardiovascular and I.V. Systems divisions. Her current board responsibilities include a range of life science investments including: EKR Therapeutics, Oceana Therapeutics, Prometheus Labs, Semprae Laboratories and SkinMedica.  Prior board responsibilities include ESP Pharma, Esprit Pharma and Xanodyne. 

 

LUCINDA HOLT

Lucinda Holt is an accomplished technology CEO, currently leading Commerce360 which offers ClickEquations, a paid search management platform. She also co-founded and led anti-spam company TurnTide that she sold to Symantec, and was CEO of Destiny WebSolutions, an Internet technology company which she grew from $250,000 to $25m.  She is currently a director of Monetate, Inc. 

 

MARY WALLACE JAENSCH

Mary Jaensch is the co-founder and CEO of Semprae Laboratories, the maker of Zestra®, the only patented, topical product clinically proven to increase feelings of arousal, desire and satisfaction for women. Prior to founding Semprae, Mary was an owner and principal of The Jannick Group, LLC/SPARK Solutions for Growth, consulting to Fortune 100 firms and leading consumer package good franchises.

 

RACHEL BRAUN SCHERL

Rachel Braun Scherl is the co-founder and President of Semprae Laboratories, the maker of Zestra®, the only patented, topical product clinically proven to increase feelings of arousal, desire and satisfaction for women. Prior to founding Semprae, Rachel was an owner and principal of The Jannick Group, LLC/SPARK Solutions for Growth, consulting to Fortune 100 firms and leading consumer package good franchises.